Based on the analysis of Seer's profitability, liquidity, and operating efficiency, Seer Inc may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At this time, Seer's Short Term Debt is relatively stable compared to the past year. Key indicators impacting Seer's financial strength include:
The essential information of the day-to-day investment outlook for Seer includes many different criteria found on its balance sheet. An individual investor should monitor Seer's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Seer.
Seer competes with Oric Pharmaceuticals, Anebulo Pharmaceuticals, Cullinan Oncology, C4 Therapeutics, and Molecular Partners. Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California. Seer Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 118 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
The reason investors look at the income statement is to determine what Seer's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
Comparative valuation techniques use various fundamental indicators to help in determining Seer's current stock value. Our valuation model uses many indicators to compare Seer value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Seer competition to find correlations between indicators driving Seer's intrinsic value. More Info.
Seer Inc is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers . At this time, Seer's Return On Equity is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Seer by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Seer Inc Systematic Risk
Seer's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Seer volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on Seer Inc correlated with the market. If Beta is less than 0 Seer generally moves in the opposite direction as compared to the market. If Seer Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Seer Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Seer is generally in the same direction as the market. If Beta > 1 Seer moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Seer Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Seer's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Seer growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of Seer help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Seer Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Seer Inc based on widely used predictive technical indicators. In general, we focus on analyzing Seer Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Seer's daily price indicators and compare them against related drivers.
When running Seer's price analysis, check to measure Seer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Seer is operating at the current time. Most of Seer's value examination focuses on studying past and present price action to predict the probability of Seer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Seer's price. Additionally, you may evaluate how the addition of Seer to your portfolios can decrease your overall portfolio volatility.